Noven Pharmaceuticals, Inc.Miami, FL, United States (NASDAQ (GS): NOVN)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Noven Pharmaceuticals Financial Statements

Noven Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Noven Pharmaceuticals Income Statement

  2007 2006 2005
Revenue ($ mil.) 83.2 60.7 52.5
Gross Profit ($ mil.) 42.1 24.2 18.5
Operating Income ($ mil.) (111.6) (9.0) (11.6)
Total Net Income ($ mil.) (45.4) 16.0 10.0
Diluted EPS (Net Income) (1.84) 0.66 0.42
More Noven Pharmaceuticals financial information

Noven Pharmaceuticals Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 24.6 21.5 23.2
Gross Profit ($ mil.) 11.8 10.2 10.2
Operating Income ($ mil.) (5.7) (5.0) (10.0)
Total Net Income ($ mil.) 4.5 2.6 1.0
Diluted EPS (Net Income) 0.18 0.11 0.03
More Noven Pharmaceuticals financial information

Noven Pharmaceuticals Stock Quote & Chart

12/01/08 16:00:05 EST • NASDAQ • 10.98 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Noven Pharmaceuticals Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 3.22 2.89 1.38
Price/Earnings Ratio -- 13.25 14.40
Price/Book Ratio 2.05 2.43 1.32
Price/Cash Flow Ratio 27.01 11.61 8.60
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Noven Pharmaceuticals Financial Ratios

Noven Pharmaceuticals Competitive Intelligence

Barr Pharmaceuticals Johnson & Johnson Wyeth Pharmaceuticals
Annual Sales ($ mil.) 2,500.6 61,095.0 16,884.2
Employees 8,900 119,200 4,500
Market Cap ($ mil.) 7,152.9 190,688.1 --

Competitive Landscape